PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Study sponsor: Protagonist Therapeutics, Inc. · PTGX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-03-15Actual
Enrollment · participants20Actual
Source updated2024-03-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.